Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文（繁體）
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Language
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Activation of the T-cell oncog...
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Permanent link
Activation of the T-cell oncogene LMO2 after gene therapy for X-linked severe combined immunodeficiency.
Bibliographic Details
Main Authors:
McCormack, M
,
Rabbitts, T
Format:
Journal article
Language:
English
Published:
2004
Holdings
Description
Similar Items
Staff View
Similar Items
LMO2 and gene therapy for severe combined immunodeficiency.
by: Fischer, A, et al.
Published: (2004)
The LMO2 T-cell oncogene is activated via chromosomal translocations or retroviral insertion during gene therapy but has no mandatory role in normal T-cell development.
by: McCormack, M, et al.
Published: (2003)
The Lmo2 oncogene initiates leukemia in mice by inducing thymocyte self-renewal.
by: McCormack, M, et al.
Published: (2010)
Combating oncogene activation associated with retrovirus-mediated gene therapy of X-linked severe combined immunodeficiency
by: B.E. Strauss, et al.
Published: (2007-05-01)
Null mutation of the Lmo4 gene or a combined null mutation of the Lmo1/Lmo3 genes causes perinatal lethality, and Lmo4 controls neural tube development in mice.
by: Tse, E, et al.
Published: (2004)